nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—epilepsy syndrome—migraine	0.452	1	CtDrD
Rufinamide—SCN1A—migraine	0.155	0.531	CbGaD
Rufinamide—SCN2A—migraine	0.137	0.469	CbGaD
Rufinamide—SCN1A—Topiramate—migraine	0.0393	0.288	CbGbCtD
Rufinamide—SCN5A—Topiramate—migraine	0.0269	0.197	CbGbCtD
Rufinamide—SCN5A—Verapamil—migraine	0.0259	0.19	CbGbCtD
Rufinamide—CYP2E1—Amitriptyline—migraine	0.0131	0.096	CbGbCtD
Rufinamide—ALB—Amitriptyline—migraine	0.0127	0.0928	CbGbCtD
Rufinamide—CYP3A4—Propranolol—migraine	0.00459	0.0336	CbGbCtD
Rufinamide—CYP3A4—Amitriptyline—migraine	0.00397	0.0291	CbGbCtD
Rufinamide—CYP3A4—Valproic Acid—migraine	0.00362	0.0265	CbGbCtD
Rufinamide—SCN3A—spinal nerve—migraine	0.00329	0.128	CbGeAlD
Rufinamide—CYP3A4—Topiramate—migraine	0.00326	0.0239	CbGbCtD
Rufinamide—CYP3A4—Verapamil—migraine	0.00315	0.0231	CbGbCtD
Rufinamide—SCN11A—peripheral nervous system—migraine	0.00176	0.0683	CbGeAlD
Rufinamide—SCN7A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00175	0.0421	CbGpPWpGaD
Rufinamide—SCN11A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00156	0.0376	CbGpPWpGaD
Rufinamide—SCN7A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00149	0.0358	CbGpPWpGaD
Rufinamide—SCN8A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00143	0.0344	CbGpPWpGaD
Rufinamide—SCN11A—nerve—migraine	0.00137	0.0532	CbGeAlD
Rufinamide—SCN8A—peripheral nervous system—migraine	0.00133	0.0517	CbGeAlD
Rufinamide—SCN11A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00133	0.0319	CbGpPWpGaD
Rufinamide—SCN8A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00122	0.0292	CbGpPWpGaD
Rufinamide—SCN9A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00116	0.0278	CbGpPWpGaD
Rufinamide—SCN3A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00111	0.0266	CbGpPWpGaD
Rufinamide—SCN4A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00106	0.0255	CbGpPWpGaD
Rufinamide—SCN2A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00106	0.0255	CbGpPWpGaD
Rufinamide—SCN8A—nerve—migraine	0.00104	0.0403	CbGeAlD
Rufinamide—SCN10A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00103	0.0246	CbGpPWpGaD
Rufinamide—SCN9A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000984	0.0236	CbGpPWpGaD
Rufinamide—SCN3A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000941	0.0226	CbGpPWpGaD
Rufinamide—SCN4A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000904	0.0217	CbGpPWpGaD
Rufinamide—SCN10A—peripheral nervous system—migraine	0.000892	0.0346	CbGeAlD
Rufinamide—SCN10A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000872	0.0209	CbGpPWpGaD
Rufinamide—SCN1A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000872	0.0209	CbGpPWpGaD
Rufinamide—GRM5—brainstem—migraine	0.000793	0.0308	CbGeAlD
Rufinamide—SCN5A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.000721	0.0173	CbGpPWpGaD
Rufinamide—SCN10A—nerve—migraine	0.000695	0.027	CbGeAlD
Rufinamide—SCN7A—L1CAM interactions—SCN1A—migraine	0.000674	0.0162	CbGpPWpGaD
Rufinamide—SCN11A—trigeminal ganglion—migraine	0.000665	0.0258	CbGeAlD
Rufinamide—SCN5A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000613	0.0147	CbGpPWpGaD
Rufinamide—SCN11A—L1CAM interactions—SCN1A—migraine	0.0006	0.0144	CbGpPWpGaD
Rufinamide—SCN7A—L1CAM interactions—SCN2A—migraine	0.000573	0.0138	CbGpPWpGaD
Rufinamide—SCN7A—trigeminal ganglion—migraine	0.000565	0.022	CbGeAlD
Rufinamide—SCN8A—L1CAM interactions—SCN1A—migraine	0.000549	0.0132	CbGpPWpGaD
Rufinamide—SCN11A—L1CAM interactions—SCN2A—migraine	0.00051	0.0123	CbGpPWpGaD
Rufinamide—SCN8A—L1CAM interactions—SCN2A—migraine	0.000467	0.0112	CbGpPWpGaD
Rufinamide—SCN8A—brainstem—migraine	0.000446	0.0173	CbGeAlD
Rufinamide—SCN9A—L1CAM interactions—SCN1A—migraine	0.000444	0.0107	CbGpPWpGaD
Rufinamide—SCN9A—trigeminal ganglion—migraine	0.000443	0.0172	CbGeAlD
Rufinamide—GRM5—head—migraine	0.000438	0.017	CbGeAlD
Rufinamide—SCN3A—L1CAM interactions—SCN1A—migraine	0.000425	0.0102	CbGpPWpGaD
Rufinamide—GRM5—nervous system—migraine	0.000415	0.0161	CbGeAlD
Rufinamide—CES1—neck—migraine	0.000409	0.0159	CbGeAlD
Rufinamide—SCN7A—cardiovascular system—migraine	0.000408	0.0159	CbGeAlD
Rufinamide—SCN2A—L1CAM interactions—SCN1A—migraine	0.000408	0.0098	CbGpPWpGaD
Rufinamide—SCN4A—L1CAM interactions—SCN1A—migraine	0.000408	0.0098	CbGpPWpGaD
Rufinamide—GRM5—central nervous system—migraine	0.0004	0.0155	CbGeAlD
Rufinamide—SCN10A—L1CAM interactions—SCN1A—migraine	0.000393	0.00945	CbGpPWpGaD
Rufinamide—GRM5—cerebellum—migraine	0.000391	0.0152	CbGeAlD
Rufinamide—SCN9A—L1CAM interactions—SCN2A—migraine	0.000378	0.00907	CbGpPWpGaD
Rufinamide—SCN3A—L1CAM interactions—SCN2A—migraine	0.000361	0.00867	CbGpPWpGaD
Rufinamide—SCN4A—L1CAM interactions—SCN2A—migraine	0.000347	0.00833	CbGpPWpGaD
Rufinamide—SCN10A—trigeminal ganglion—migraine	0.000337	0.0131	CbGeAlD
Rufinamide—SCN1A—brainstem—migraine	0.000337	0.0131	CbGeAlD
Rufinamide—SCN1A—L1CAM interactions—SCN2A—migraine	0.000335	0.00803	CbGpPWpGaD
Rufinamide—SCN10A—L1CAM interactions—SCN2A—migraine	0.000335	0.00803	CbGpPWpGaD
Rufinamide—SCN11A—head—migraine	0.000325	0.0126	CbGeAlD
Rufinamide—GRM5—brain—migraine	0.000317	0.0123	CbGeAlD
Rufinamide—SCN2A—brainstem—migraine	0.000309	0.012	CbGeAlD
Rufinamide—SCN11A—nervous system—migraine	0.000308	0.012	CbGeAlD
Rufinamide—SCN11A—central nervous system—migraine	0.000297	0.0115	CbGeAlD
Rufinamide—ALB—Scavenging of heme from plasma—LRP1—migraine	0.000293	0.00704	CbGpPWpGaD
Rufinamide—GRM5—G alpha (q) signalling events—HTR2B—migraine	0.000286	0.00686	CbGpPWpGaD
Rufinamide—SCN5A—L1CAM interactions—SCN1A—migraine	0.000277	0.00664	CbGpPWpGaD
Rufinamide—SCN7A—head—migraine	0.000277	0.0107	CbGeAlD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000255	0.00613	CbGpPWpGaD
Rufinamide—CES1—cardiovascular system—migraine	0.000255	0.00989	CbGeAlD
Rufinamide—SCN7A—Axon guidance—SCN1A—migraine	0.000255	0.00611	CbGpPWpGaD
Rufinamide—SCN8A—head—migraine	0.000246	0.00957	CbGeAlD
Rufinamide—CES1—Fluoropyrimidine Activity—MTHFR—migraine	0.00024	0.00576	CbGpPWpGaD
Rufinamide—SCN11A—brain—migraine	0.000236	0.00915	CbGeAlD
Rufinamide—SCN5A—L1CAM interactions—SCN2A—migraine	0.000235	0.00565	CbGpPWpGaD
Rufinamide—SCN8A—nervous system—migraine	0.000234	0.00907	CbGeAlD
Rufinamide—SCN11A—Axon guidance—SCN1A—migraine	0.000227	0.00545	CbGpPWpGaD
Rufinamide—SCN8A—central nervous system—migraine	0.000225	0.00873	CbGeAlD
Rufinamide—SCN5A—cardiovascular system—migraine	0.000221	0.00859	CbGeAlD
Rufinamide—SCN8A—cerebellum—migraine	0.00022	0.00854	CbGeAlD
Rufinamide—SCN7A—Axon guidance—SCN2A—migraine	0.000216	0.0052	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—RAMP1—migraine	0.000213	0.00512	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—CALCRL—migraine	0.000213	0.00512	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—SCN1A—migraine	0.000207	0.00498	CbGpPWpGaD
Rufinamide—SCN7A—brain—migraine	0.0002	0.00778	CbGeAlD
Rufinamide—SCN4A—head—migraine	0.000193	0.0075	CbGeAlD
Rufinamide—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—migraine	0.000193	0.00463	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—SCN2A—migraine	0.000193	0.00463	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000188	0.0045	CbGpPWpGaD
Rufinamide—SCN1A—head—migraine	0.000186	0.00723	CbGeAlD
Rufinamide—SCN4A—nervous system—migraine	0.000183	0.00711	CbGeAlD
Rufinamide—SCN7A—Developmental Biology—SCN1A—migraine	0.000182	0.00436	CbGpPWpGaD
Rufinamide—SCN8A—brain—migraine	0.000179	0.00693	CbGeAlD
Rufinamide—SCN1A—nervous system—migraine	0.000177	0.00686	CbGeAlD
Rufinamide—GRM5—G alpha (q) signalling events—NPS—migraine	0.000176	0.00424	CbGpPWpGaD
Rufinamide—GRM5—G alpha (q) signalling events—TAC1—migraine	0.000176	0.00424	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—SCN2A—migraine	0.000176	0.00424	CbGpPWpGaD
Rufinamide—SCN4A—central nervous system—migraine	0.000176	0.00685	CbGeAlD
Rufinamide—GRM5—G alpha (q) signalling events—HTR2C—migraine	0.000173	0.00416	CbGpPWpGaD
Rufinamide—CES1—head—migraine	0.000173	0.0067	CbGeAlD
Rufinamide—SCN2A—head—migraine	0.000171	0.00664	CbGeAlD
Rufinamide—SCN1A—central nervous system—migraine	0.00017	0.0066	CbGeAlD
Rufinamide—GRM5—G alpha (q) signalling events—EDNRA—migraine	0.000168	0.00404	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—SCN1A—migraine	0.000168	0.00403	CbGpPWpGaD
Rufinamide—SCN1A—cerebellum—migraine	0.000166	0.00645	CbGeAlD
Rufinamide—SCN10A—head—migraine	0.000165	0.0064	CbGeAlD
Rufinamide—CES1—nervous system—migraine	0.000164	0.00635	CbGeAlD
Rufinamide—SCN2A—nervous system—migraine	0.000162	0.00629	CbGeAlD
Rufinamide—SCN11A—Developmental Biology—SCN1A—migraine	0.000162	0.00389	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—SCN1A—migraine	0.000161	0.00385	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—HTR3A—migraine	0.00016	0.00383	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000158	0.00379	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000158	0.00379	CbGpPWpGaD
Rufinamide—Decreased appetite—Amitriptyline—migraine	0.000158	0.00306	CcSEcCtD
Rufinamide—Breast disorder—Timolol—migraine	0.000158	0.00306	CcSEcCtD
Rufinamide—CES1—central nervous system—migraine	0.000158	0.00612	CbGeAlD
Rufinamide—Vision blurred—Verapamil—migraine	0.000157	0.00304	CcSEcCtD
Rufinamide—SCN9A—brain—migraine	0.000157	0.00609	CbGeAlD
Rufinamide—Convulsion—Propranolol—migraine	0.000157	0.00304	CcSEcCtD
Rufinamide—Pollakiuria—Valproic Acid—migraine	0.000157	0.00303	CcSEcCtD
Rufinamide—Fatigue—Amitriptyline—migraine	0.000156	0.00303	CcSEcCtD
Rufinamide—SCN10A—nervous system—migraine	0.000156	0.00607	CbGeAlD
Rufinamide—Nasopharyngitis—Timolol—migraine	0.000156	0.00302	CcSEcCtD
Rufinamide—SCN2A—central nervous system—migraine	0.000156	0.00606	CbGeAlD
Rufinamide—Tremor—Verapamil—migraine	0.000156	0.00302	CcSEcCtD
Rufinamide—Polyuria—Topiramate—migraine	0.000156	0.00302	CcSEcCtD
Rufinamide—Constipation—Amitriptyline—migraine	0.000155	0.00301	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—HTR1D—migraine	0.000155	0.00372	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000155	0.00372	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—SCN2A—migraine	0.000154	0.00371	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—SCN1A—migraine	0.000154	0.0037	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—SCN1A—migraine	0.000154	0.0037	CbGpPWpGaD
Rufinamide—Weight decreased—Valproic Acid—migraine	0.000153	0.00297	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000153	0.00297	CcSEcCtD
Rufinamide—Agitation—Verapamil—migraine	0.000153	0.00297	CcSEcCtD
Rufinamide—Ataxia—Gabapentin—migraine	0.000153	0.00296	CcSEcCtD
Rufinamide—SCN2A—cerebellum—migraine	0.000153	0.00592	CbGeAlD
Rufinamide—Pneumonia—Valproic Acid—migraine	0.000152	0.00295	CcSEcCtD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000151	0.00362	CbGpPWpGaD
Rufinamide—SCN10A—central nervous system—migraine	0.000151	0.00584	CbGeAlD
Rufinamide—SCN3A—head—migraine	0.00015	0.00583	CbGeAlD
Rufinamide—SCN5A—head—migraine	0.00015	0.00582	CbGeAlD
Rufinamide—Vertigo—Verapamil—migraine	0.00015	0.0029	CcSEcCtD
Rufinamide—SCN10A—Axon guidance—SCN1A—migraine	0.000149	0.00357	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—SCN1A—migraine	0.000148	0.00356	CbGpPWpGaD
Rufinamide—Breast disorder—Gabapentin—migraine	0.000147	0.00285	CcSEcCtD
Rufinamide—Infection—Propranolol—migraine	0.000147	0.00284	CcSEcCtD
Rufinamide—Increased appetite—Topiramate—migraine	0.000146	0.00282	CcSEcCtD
Rufinamide—Nasopharyngitis—Gabapentin—migraine	0.000145	0.00282	CcSEcCtD
Rufinamide—Nervous system disorder—Propranolol—migraine	0.000145	0.00281	CcSEcCtD
Rufinamide—Convulsion—Verapamil—migraine	0.000144	0.0028	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—HTR2B—migraine	0.000144	0.00346	CbGpPWpGaD
Rufinamide—Skin disorder—Propranolol—migraine	0.000144	0.00278	CcSEcCtD
Rufinamide—Hepatobiliary disease—Valproic Acid—migraine	0.000143	0.00277	CcSEcCtD
Rufinamide—SCN9A—Axon guidance—SCN2A—migraine	0.000143	0.00343	CbGpPWpGaD
Rufinamide—Epistaxis—Valproic Acid—migraine	0.000143	0.00276	CcSEcCtD
Rufinamide—SCN3A—nervous system—migraine	0.000142	0.00553	CbGeAlD
Rufinamide—SCN5A—nervous system—migraine	0.000142	0.00552	CbGeAlD
Rufinamide—Sinusitis—Valproic Acid—migraine	0.000142	0.00275	CcSEcCtD
Rufinamide—SCN7A—Developmental Biology—MEF2D—migraine	0.000141	0.00339	CbGpPWpGaD
Rufinamide—Dysuria—Timolol—migraine	0.000141	0.00273	CcSEcCtD
Rufinamide—Influenza—Gabapentin—migraine	0.000141	0.00272	CcSEcCtD
Rufinamide—SCN4A—brain—migraine	0.00014	0.00544	CbGeAlD
Rufinamide—SCN11A—Developmental Biology—SCN2A—migraine	0.000138	0.00331	CbGpPWpGaD
Rufinamide—SCN3A—central nervous system—migraine	0.000137	0.00533	CbGeAlD
Rufinamide—SCN5A—central nervous system—migraine	0.000137	0.00531	CbGeAlD
Rufinamide—Diplopia—Topiramate—migraine	0.000137	0.00265	CcSEcCtD
Rufinamide—Weight decreased—Timolol—migraine	0.000137	0.00265	CcSEcCtD
Rufinamide—SCN3A—Axon guidance—SCN2A—migraine	0.000136	0.00328	CbGpPWpGaD
Rufinamide—Rhinitis—Valproic Acid—migraine	0.000136	0.00264	CcSEcCtD
Rufinamide—Bronchitis—Gabapentin—migraine	0.000135	0.00262	CcSEcCtD
Rufinamide—Infection—Verapamil—migraine	0.000135	0.00262	CcSEcCtD
Rufinamide—SCN1A—brain—migraine	0.000135	0.00524	CbGeAlD
Rufinamide—SCN3A—cerebellum—migraine	0.000134	0.00521	CbGeAlD
Rufinamide—Urinary tract disorder—Valproic Acid—migraine	0.000134	0.0026	CcSEcCtD
Rufinamide—Insomnia—Propranolol—migraine	0.000134	0.00259	CcSEcCtD
Rufinamide—Urethral disorder—Valproic Acid—migraine	0.000133	0.00258	CcSEcCtD
Rufinamide—Dysuria—Gabapentin—migraine	0.000131	0.00255	CcSEcCtD
Rufinamide—Somnolence—Propranolol—migraine	0.000131	0.00255	CcSEcCtD
Rufinamide—SCN4A—Axon guidance—SCN2A—migraine	0.000131	0.00315	CbGpPWpGaD
Rufinamide—Asthenia—Amitriptyline—migraine	0.00013	0.00252	CcSEcCtD
Rufinamide—Dyspepsia—Propranolol—migraine	0.00013	0.00252	CcSEcCtD
Rufinamide—Pollakiuria—Gabapentin—migraine	0.00013	0.00252	CcSEcCtD
Rufinamide—Ataxia—Topiramate—migraine	0.000129	0.00249	CcSEcCtD
Rufinamide—Decreased appetite—Propranolol—migraine	0.000128	0.00249	CcSEcCtD
Rufinamide—Pruritus—Amitriptyline—migraine	0.000128	0.00249	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Propranolol—migraine	0.000128	0.00247	CcSEcCtD
Rufinamide—Fatigue—Propranolol—migraine	0.000127	0.00247	CcSEcCtD
Rufinamide—Weight decreased—Gabapentin—migraine	0.000127	0.00246	CcSEcCtD
Rufinamide—Epistaxis—Timolol—migraine	0.000127	0.00246	CcSEcCtD
Rufinamide—Eye disorder—Valproic Acid—migraine	0.000127	0.00246	CcSEcCtD
Rufinamide—SCN1A—Axon guidance—SCN2A—migraine	0.000126	0.00304	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—SCN2A—migraine	0.000126	0.00304	CbGpPWpGaD
Rufinamide—Constipation—Propranolol—migraine	0.000126	0.00245	CcSEcCtD
Rufinamide—Sinusitis—Timolol—migraine	0.000126	0.00245	CcSEcCtD
Rufinamide—Pneumonia—Gabapentin—migraine	0.000126	0.00244	CcSEcCtD
Rufinamide—SCN11A—Developmental Biology—MEF2D—migraine	0.000126	0.00302	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—SCN2A—migraine	0.000126	0.00302	CbGpPWpGaD
Rufinamide—Infestation—Gabapentin—migraine	0.000125	0.00243	CcSEcCtD
Rufinamide—Infestation NOS—Gabapentin—migraine	0.000125	0.00243	CcSEcCtD
Rufinamide—CES1—brain—migraine	0.000125	0.00486	CbGeAlD
Rufinamide—Abdominal pain upper—Topiramate—migraine	0.000125	0.00242	CcSEcCtD
Rufinamide—Diarrhoea—Amitriptyline—migraine	0.000124	0.00241	CcSEcCtD
Rufinamide—SCN2A—brain—migraine	0.000124	0.00481	CbGeAlD
Rufinamide—Breast disorder—Topiramate—migraine	0.000124	0.00239	CcSEcCtD
Rufinamide—Insomnia—Verapamil—migraine	0.000123	0.00238	CcSEcCtD
Rufinamide—Immune system disorder—Valproic Acid—migraine	0.000123	0.00237	CcSEcCtD
Rufinamide—Nasopharyngitis—Topiramate—migraine	0.000122	0.00237	CcSEcCtD
Rufinamide—Mediastinal disorder—Valproic Acid—migraine	0.000122	0.00237	CcSEcCtD
Rufinamide—Rhinitis—Timolol—migraine	0.000121	0.00235	CcSEcCtD
Rufinamide—Somnolence—Verapamil—migraine	0.000121	0.00234	CcSEcCtD
Rufinamide—GRM5—GPCR downstream signaling—CALCRL—migraine	0.000121	0.00289	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—RAMP1—migraine	0.000121	0.00289	CbGpPWpGaD
Rufinamide—Dizziness—Amitriptyline—migraine	0.00012	0.00233	CcSEcCtD
Rufinamide—SCN9A—Developmental Biology—SCN1A—migraine	0.00012	0.00288	CbGpPWpGaD
Rufinamide—Dyspepsia—Verapamil—migraine	0.00012	0.00232	CcSEcCtD
Rufinamide—SCN10A—brain—migraine	0.000119	0.00464	CbGeAlD
Rufinamide—Haematuria—Gabapentin—migraine	0.000119	0.00231	CcSEcCtD
Rufinamide—CES1—NRF2 pathway—SLC6A4—migraine	0.000119	0.00286	CbGpPWpGaD
Rufinamide—Mental disorder—Valproic Acid—migraine	0.000119	0.0023	CcSEcCtD
Rufinamide—Hepatobiliary disease—Gabapentin—migraine	0.000118	0.0023	CcSEcCtD
Rufinamide—Epistaxis—Gabapentin—migraine	0.000118	0.00229	CcSEcCtD
Rufinamide—Malnutrition—Valproic Acid—migraine	0.000118	0.00229	CcSEcCtD
Rufinamide—Sinusitis—Gabapentin—migraine	0.000118	0.00228	CcSEcCtD
Rufinamide—Fatigue—Verapamil—migraine	0.000117	0.00227	CcSEcCtD
Rufinamide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.000117	0.00281	CbGpPWpGaD
Rufinamide—Constipation—Verapamil—migraine	0.000116	0.00225	CcSEcCtD
Rufinamide—Vomiting—Amitriptyline—migraine	0.000115	0.00224	CcSEcCtD
Rufinamide—SCN8A—Developmental Biology—MEF2D—migraine	0.000115	0.00276	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—SCN1A—migraine	0.000115	0.00275	CbGpPWpGaD
Rufinamide—Rash—Amitriptyline—migraine	0.000114	0.00222	CcSEcCtD
Rufinamide—Dermatitis—Amitriptyline—migraine	0.000114	0.00222	CcSEcCtD
Rufinamide—Back pain—Valproic Acid—migraine	0.000114	0.00221	CcSEcCtD
Rufinamide—Headache—Amitriptyline—migraine	0.000114	0.0022	CcSEcCtD
Rufinamide—Bronchitis—Topiramate—migraine	0.000114	0.0022	CcSEcCtD
Rufinamide—Eye disorder—Timolol—migraine	0.000113	0.00219	CcSEcCtD
Rufinamide—Rhinitis—Gabapentin—migraine	0.000113	0.00218	CcSEcCtD
Rufinamide—Cardiac disorder—Timolol—migraine	0.000112	0.00217	CcSEcCtD
Rufinamide—Vision blurred—Valproic Acid—migraine	0.000111	0.00216	CcSEcCtD
Rufinamide—Urinary tract disorder—Gabapentin—migraine	0.000111	0.00215	CcSEcCtD
Rufinamide—Tremor—Valproic Acid—migraine	0.000111	0.00214	CcSEcCtD
Rufinamide—Neutropenia—Topiramate—migraine	0.000111	0.00214	CcSEcCtD
Rufinamide—Dysuria—Topiramate—migraine	0.000111	0.00214	CcSEcCtD
Rufinamide—Urethral disorder—Gabapentin—migraine	0.00011	0.00214	CcSEcCtD
Rufinamide—SCN2A—Developmental Biology—SCN1A—migraine	0.00011	0.00264	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—SCN1A—migraine	0.00011	0.00264	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CALCRL—migraine	0.000109	0.00263	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—RAMP1—migraine	0.000109	0.00263	CbGpPWpGaD
Rufinamide—Pollakiuria—Topiramate—migraine	0.000109	0.00212	CcSEcCtD
Rufinamide—Anaemia—Valproic Acid—migraine	0.000109	0.00212	CcSEcCtD
Rufinamide—Immune system disorder—Timolol—migraine	0.000109	0.00211	CcSEcCtD
Rufinamide—SCN3A—brain—migraine	0.000109	0.00423	CbGeAlD
Rufinamide—Hypersensitivity—Propranolol—migraine	0.000109	0.00211	CcSEcCtD
Rufinamide—Mediastinal disorder—Timolol—migraine	0.000109	0.00211	CcSEcCtD
Rufinamide—SCN5A—brain—migraine	0.000109	0.00422	CbGeAlD
Rufinamide—Agitation—Valproic Acid—migraine	0.000109	0.0021	CcSEcCtD
Rufinamide—Nausea—Amitriptyline—migraine	0.000108	0.00209	CcSEcCtD
Rufinamide—Weight decreased—Topiramate—migraine	0.000107	0.00207	CcSEcCtD
Rufinamide—GRM5—G alpha (q) signalling events—HTR2A—migraine	0.000106	0.00255	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—SCN1A—migraine	0.000106	0.00255	CbGpPWpGaD
Rufinamide—Vertigo—Valproic Acid—migraine	0.000106	0.00206	CcSEcCtD
Rufinamide—Asthenia—Propranolol—migraine	0.000106	0.00205	CcSEcCtD
Rufinamide—Pneumonia—Topiramate—migraine	0.000106	0.00205	CcSEcCtD
Rufinamide—Mental disorder—Timolol—migraine	0.000106	0.00205	CcSEcCtD
Rufinamide—Leukopenia—Valproic Acid—migraine	0.000106	0.00205	CcSEcCtD
Rufinamide—Infestation—Topiramate—migraine	0.000105	0.00204	CcSEcCtD
Rufinamide—Infestation NOS—Topiramate—migraine	0.000105	0.00204	CcSEcCtD
Rufinamide—Malnutrition—Timolol—migraine	0.000105	0.00204	CcSEcCtD
Rufinamide—Eye disorder—Gabapentin—migraine	0.000105	0.00204	CcSEcCtD
Rufinamide—CYP2E1—cardiovascular system—migraine	0.000105	0.00407	CbGeAlD
Rufinamide—SCN5A—Axon guidance—SCN1A—migraine	0.000105	0.00251	CbGpPWpGaD
Rufinamide—Cardiac disorder—Gabapentin—migraine	0.000104	0.00202	CcSEcCtD
Rufinamide—SCN9A—Developmental Biology—SCN2A—migraine	0.000102	0.00244	CbGpPWpGaD
Rufinamide—Immune system disorder—Gabapentin—migraine	0.000102	0.00197	CcSEcCtD
Rufinamide—Mediastinal disorder—Gabapentin—migraine	0.000101	0.00196	CcSEcCtD
Rufinamide—Diarrhoea—Propranolol—migraine	0.000101	0.00196	CcSEcCtD
Rufinamide—Haematuria—Topiramate—migraine	0.000101	0.00195	CcSEcCtD
Rufinamide—Anxiety—Valproic Acid—migraine	0.0001	0.00194	CcSEcCtD
Rufinamide—Hypersensitivity—Verapamil—migraine	0.0001	0.00194	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	9.99e-05	0.00193	CcSEcCtD
Rufinamide—Epistaxis—Topiramate—migraine	9.94e-05	0.00193	CcSEcCtD
Rufinamide—Vision blurred—Timolol—migraine	9.91e-05	0.00192	CcSEcCtD
Rufinamide—Sinusitis—Topiramate—migraine	9.89e-05	0.00192	CcSEcCtD
Rufinamide—Mental disorder—Gabapentin—migraine	9.85e-05	0.00191	CcSEcCtD
Rufinamide—Malnutrition—Gabapentin—migraine	9.79e-05	0.0019	CcSEcCtD
Rufinamide—Dizziness—Propranolol—migraine	9.77e-05	0.00189	CcSEcCtD
Rufinamide—Asthenia—Verapamil—migraine	9.75e-05	0.00189	CcSEcCtD
Rufinamide—SCN3A—Developmental Biology—SCN2A—migraine	9.74e-05	0.00234	CbGpPWpGaD
Rufinamide—Pruritus—Verapamil—migraine	9.62e-05	0.00186	CcSEcCtD
Rufinamide—Infection—Valproic Acid—migraine	9.58e-05	0.00186	CcSEcCtD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	9.5e-05	0.00228	CbGpPWpGaD
Rufinamide—Rhinitis—Topiramate—migraine	9.49e-05	0.00184	CcSEcCtD
Rufinamide—Back pain—Gabapentin—migraine	9.47e-05	0.00184	CcSEcCtD
Rufinamide—Nervous system disorder—Valproic Acid—migraine	9.45e-05	0.00183	CcSEcCtD
Rufinamide—Vertigo—Timolol—migraine	9.45e-05	0.00183	CcSEcCtD
Rufinamide—Thrombocytopenia—Valproic Acid—migraine	9.44e-05	0.00183	CcSEcCtD
Rufinamide—Vomiting—Propranolol—migraine	9.4e-05	0.00182	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—HTR1B—migraine	9.39e-05	0.00225	CbGpPWpGaD
Rufinamide—Skin disorder—Valproic Acid—migraine	9.36e-05	0.00181	CcSEcCtD
Rufinamide—SCN4A—Developmental Biology—SCN2A—migraine	9.36e-05	0.00225	CbGpPWpGaD
Rufinamide—Urinary tract disorder—Topiramate—migraine	9.34e-05	0.00181	CcSEcCtD
Rufinamide—Rash—Propranolol—migraine	9.32e-05	0.00181	CcSEcCtD
Rufinamide—SCN9A—Developmental Biology—MEF2D—migraine	9.31e-05	0.00224	CbGpPWpGaD
Rufinamide—Dermatitis—Propranolol—migraine	9.31e-05	0.0018	CcSEcCtD
Rufinamide—Diarrhoea—Verapamil—migraine	9.3e-05	0.0018	CcSEcCtD
Rufinamide—Urethral disorder—Topiramate—migraine	9.28e-05	0.0018	CcSEcCtD
Rufinamide—Vision blurred—Gabapentin—migraine	9.23e-05	0.00179	CcSEcCtD
Rufinamide—Anorexia—Valproic Acid—migraine	9.19e-05	0.00178	CcSEcCtD
Rufinamide—Tremor—Gabapentin—migraine	9.17e-05	0.00178	CcSEcCtD
Rufinamide—Anaemia—Gabapentin—migraine	9.05e-05	0.00175	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—HTR1A—migraine	9.04e-05	0.00217	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—SCN2A—migraine	9.02e-05	0.00217	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—SCN2A—migraine	9.02e-05	0.00217	CbGpPWpGaD
Rufinamide—Agitation—Gabapentin—migraine	9e-05	0.00174	CcSEcCtD
Rufinamide—CES1—NRF2 pathway—TGFBR2—migraine	8.99e-05	0.00216	CbGpPWpGaD
Rufinamide—Dizziness—Verapamil—migraine	8.99e-05	0.00174	CcSEcCtD
Rufinamide—Anxiety—Timolol—migraine	8.92e-05	0.00173	CcSEcCtD
Rufinamide—SCN3A—Developmental Biology—MEF2D—migraine	8.91e-05	0.00214	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—NPS—migraine	8.9e-05	0.00214	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—TAC1—migraine	8.9e-05	0.00214	CbGpPWpGaD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	8.89e-05	0.00172	CcSEcCtD
Rufinamide—SCN5A—Axon guidance—SCN2A—migraine	8.89e-05	0.00213	CbGpPWpGaD
Rufinamide—Eye disorder—Topiramate—migraine	8.84e-05	0.00171	CcSEcCtD
Rufinamide—Vertigo—Gabapentin—migraine	8.8e-05	0.0017	CcSEcCtD
Rufinamide—Cardiac disorder—Topiramate—migraine	8.78e-05	0.0017	CcSEcCtD
Rufinamide—Nausea—Propranolol—migraine	8.78e-05	0.0017	CcSEcCtD
Rufinamide—Leukopenia—Gabapentin—migraine	8.76e-05	0.0017	CcSEcCtD
Rufinamide—GRM5—GPCR downstream signaling—HTR1D—migraine	8.76e-05	0.0021	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—HTR2C—migraine	8.73e-05	0.0021	CbGpPWpGaD
Rufinamide—Insomnia—Valproic Acid—migraine	8.72e-05	0.00169	CcSEcCtD
Rufinamide—ALB—brain—migraine	8.69e-05	0.00337	CbGeAlD
Rufinamide—Vomiting—Verapamil—migraine	8.64e-05	0.00167	CcSEcCtD
Rufinamide—Rash—Verapamil—migraine	8.57e-05	0.00166	CcSEcCtD
Rufinamide—Somnolence—Valproic Acid—migraine	8.57e-05	0.00166	CcSEcCtD
Rufinamide—Dermatitis—Verapamil—migraine	8.56e-05	0.00166	CcSEcCtD
Rufinamide—SCN2A—Developmental Biology—MEF2D—migraine	8.56e-05	0.00205	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MEF2D—migraine	8.56e-05	0.00205	CbGpPWpGaD
Rufinamide—Immune system disorder—Topiramate—migraine	8.55e-05	0.00166	CcSEcCtD
Rufinamide—Mediastinal disorder—Topiramate—migraine	8.53e-05	0.00165	CcSEcCtD
Rufinamide—Infection—Timolol—migraine	8.52e-05	0.00165	CcSEcCtD
Rufinamide—Headache—Verapamil—migraine	8.52e-05	0.00165	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—EDNRA—migraine	8.49e-05	0.00204	CbGpPWpGaD
Rufinamide—Dyspepsia—Valproic Acid—migraine	8.49e-05	0.00164	CcSEcCtD
Rufinamide—Convulsion—Gabapentin—migraine	8.48e-05	0.00164	CcSEcCtD
Rufinamide—Nervous system disorder—Timolol—migraine	8.42e-05	0.00163	CcSEcCtD
Rufinamide—Decreased appetite—Valproic Acid—migraine	8.38e-05	0.00162	CcSEcCtD
Rufinamide—Skin disorder—Timolol—migraine	8.33e-05	0.00161	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Valproic Acid—migraine	8.32e-05	0.00161	CcSEcCtD
Rufinamide—Fatigue—Valproic Acid—migraine	8.31e-05	0.00161	CcSEcCtD
Rufinamide—Anxiety—Gabapentin—migraine	8.31e-05	0.00161	CcSEcCtD
Rufinamide—Mental disorder—Topiramate—migraine	8.29e-05	0.00161	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	8.28e-05	0.0016	CcSEcCtD
Rufinamide—SCN1A—Developmental Biology—MEF2D—migraine	8.25e-05	0.00198	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MEF2D—migraine	8.25e-05	0.00198	CbGpPWpGaD
Rufinamide—Constipation—Valproic Acid—migraine	8.24e-05	0.0016	CcSEcCtD
Rufinamide—Malnutrition—Topiramate—migraine	8.24e-05	0.0016	CcSEcCtD
Rufinamide—Anorexia—Timolol—migraine	8.18e-05	0.00158	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—CALCA—migraine	8.17e-05	0.00196	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—HTR2B—migraine	8.14e-05	0.00195	CbGpPWpGaD
Rufinamide—Nausea—Verapamil—migraine	8.08e-05	0.00156	CcSEcCtD
Rufinamide—Back pain—Topiramate—migraine	7.97e-05	0.00154	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—HTR1D—migraine	7.95e-05	0.00191	CbGpPWpGaD
Rufinamide—Infection—Gabapentin—migraine	7.94e-05	0.00154	CcSEcCtD
Rufinamide—Nervous system disorder—Gabapentin—migraine	7.84e-05	0.00152	CcSEcCtD
Rufinamide—Thrombocytopenia—Gabapentin—migraine	7.82e-05	0.00152	CcSEcCtD
Rufinamide—Vision blurred—Topiramate—migraine	7.76e-05	0.0015	CcSEcCtD
Rufinamide—Skin disorder—Gabapentin—migraine	7.76e-05	0.0015	CcSEcCtD
Rufinamide—Insomnia—Timolol—migraine	7.76e-05	0.0015	CcSEcCtD
Rufinamide—Tremor—Topiramate—migraine	7.72e-05	0.0015	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—HTR7—migraine	7.64e-05	0.00184	CbGpPWpGaD
Rufinamide—Somnolence—Timolol—migraine	7.63e-05	0.00148	CcSEcCtD
Rufinamide—Anorexia—Gabapentin—migraine	7.62e-05	0.00148	CcSEcCtD
Rufinamide—Anaemia—Topiramate—migraine	7.61e-05	0.00148	CcSEcCtD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—HTR1A—migraine	7.58e-05	0.00182	CbGpPWpGaD
Rufinamide—Agitation—Topiramate—migraine	7.57e-05	0.00147	CcSEcCtD
Rufinamide—Dyspepsia—Timolol—migraine	7.55e-05	0.00146	CcSEcCtD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—TAC1—migraine	7.47e-05	0.00179	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—SCN1A—migraine	7.46e-05	0.00179	CbGpPWpGaD
Rufinamide—Decreased appetite—Timolol—migraine	7.46e-05	0.00145	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Timolol—migraine	7.41e-05	0.00144	CcSEcCtD
Rufinamide—Vertigo—Topiramate—migraine	7.4e-05	0.00143	CcSEcCtD
Rufinamide—Fatigue—Timolol—migraine	7.4e-05	0.00143	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—HTR2B—migraine	7.39e-05	0.00178	CbGpPWpGaD
Rufinamide—Leukopenia—Topiramate—migraine	7.37e-05	0.00143	CcSEcCtD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—SLC6A4—migraine	7.32e-05	0.00176	CbGpPWpGaD
Rufinamide—Insomnia—Gabapentin—migraine	7.23e-05	0.0014	CcSEcCtD
Rufinamide—Convulsion—Topiramate—migraine	7.14e-05	0.00138	CcSEcCtD
Rufinamide—Somnolence—Gabapentin—migraine	7.1e-05	0.00138	CcSEcCtD
Rufinamide—Hypersensitivity—Valproic Acid—migraine	7.1e-05	0.00138	CcSEcCtD
Rufinamide—CYP2E1—head—migraine	7.1e-05	0.00276	CbGeAlD
Rufinamide—Dyspepsia—Gabapentin—migraine	7.03e-05	0.00136	CcSEcCtD
Rufinamide—Anxiety—Topiramate—migraine	6.99e-05	0.00135	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	6.96e-05	0.00135	CcSEcCtD
Rufinamide—Decreased appetite—Gabapentin—migraine	6.95e-05	0.00135	CcSEcCtD
Rufinamide—Asthenia—Valproic Acid—migraine	6.92e-05	0.00134	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Gabapentin—migraine	6.9e-05	0.00134	CcSEcCtD
Rufinamide—Fatigue—Gabapentin—migraine	6.89e-05	0.00133	CcSEcCtD
Rufinamide—Constipation—Gabapentin—migraine	6.83e-05	0.00132	CcSEcCtD
Rufinamide—Pruritus—Valproic Acid—migraine	6.82e-05	0.00132	CcSEcCtD
Rufinamide—CYP2E1—nervous system—migraine	6.73e-05	0.00261	CbGeAlD
Rufinamide—Infection—Topiramate—migraine	6.68e-05	0.00129	CcSEcCtD
Rufinamide—Diarrhoea—Valproic Acid—migraine	6.6e-05	0.00128	CcSEcCtD
Rufinamide—Nervous system disorder—Topiramate—migraine	6.59e-05	0.00128	CcSEcCtD
Rufinamide—Thrombocytopenia—Topiramate—migraine	6.58e-05	0.00128	CcSEcCtD
Rufinamide—Skin disorder—Topiramate—migraine	6.53e-05	0.00127	CcSEcCtD
Rufinamide—CYP2E1—central nervous system—migraine	6.48e-05	0.00251	CbGeAlD
Rufinamide—GRM5—Signaling Pathways—RAMP1—migraine	6.47e-05	0.00155	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CALCRL—migraine	6.47e-05	0.00155	CbGpPWpGaD
Rufinamide—Anorexia—Topiramate—migraine	6.41e-05	0.00124	CcSEcCtD
Rufinamide—Dizziness—Valproic Acid—migraine	6.37e-05	0.00124	CcSEcCtD
Rufinamide—SCN5A—Developmental Biology—SCN2A—migraine	6.34e-05	0.00152	CbGpPWpGaD
Rufinamide—CYP2E1—cerebellum—migraine	6.33e-05	0.00246	CbGeAlD
Rufinamide—Hypersensitivity—Timolol—migraine	6.32e-05	0.00122	CcSEcCtD
Rufinamide—Asthenia—Timolol—migraine	6.16e-05	0.00119	CcSEcCtD
Rufinamide—Vomiting—Valproic Acid—migraine	6.13e-05	0.00119	CcSEcCtD
Rufinamide—Insomnia—Topiramate—migraine	6.08e-05	0.00118	CcSEcCtD
Rufinamide—Rash—Valproic Acid—migraine	6.08e-05	0.00118	CcSEcCtD
Rufinamide—Dermatitis—Valproic Acid—migraine	6.07e-05	0.00118	CcSEcCtD
Rufinamide—Pruritus—Timolol—migraine	6.07e-05	0.00118	CcSEcCtD
Rufinamide—Headache—Valproic Acid—migraine	6.04e-05	0.00117	CcSEcCtD
Rufinamide—Somnolence—Topiramate—migraine	5.98e-05	0.00116	CcSEcCtD
Rufinamide—Dyspepsia—Topiramate—migraine	5.92e-05	0.00115	CcSEcCtD
Rufinamide—Hypersensitivity—Gabapentin—migraine	5.89e-05	0.00114	CcSEcCtD
Rufinamide—Diarrhoea—Timolol—migraine	5.87e-05	0.00114	CcSEcCtD
Rufinamide—Decreased appetite—Topiramate—migraine	5.84e-05	0.00113	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Topiramate—migraine	5.8e-05	0.00112	CcSEcCtD
Rufinamide—SCN5A—Developmental Biology—MEF2D—migraine	5.8e-05	0.00139	CbGpPWpGaD
Rufinamide—Fatigue—Topiramate—migraine	5.8e-05	0.00112	CcSEcCtD
Rufinamide—Constipation—Topiramate—migraine	5.75e-05	0.00111	CcSEcCtD
Rufinamide—Asthenia—Gabapentin—migraine	5.73e-05	0.00111	CcSEcCtD
Rufinamide—Nausea—Valproic Acid—migraine	5.73e-05	0.00111	CcSEcCtD
Rufinamide—Dizziness—Timolol—migraine	5.67e-05	0.0011	CcSEcCtD
Rufinamide—Pruritus—Gabapentin—migraine	5.65e-05	0.0011	CcSEcCtD
Rufinamide—Diarrhoea—Gabapentin—migraine	5.47e-05	0.00106	CcSEcCtD
Rufinamide—Vomiting—Timolol—migraine	5.46e-05	0.00106	CcSEcCtD
Rufinamide—CYP3A4—nervous system—migraine	5.41e-05	0.0021	CbGeAlD
Rufinamide—Rash—Timolol—migraine	5.41e-05	0.00105	CcSEcCtD
Rufinamide—Dermatitis—Timolol—migraine	5.41e-05	0.00105	CcSEcCtD
Rufinamide—Headache—Timolol—migraine	5.38e-05	0.00104	CcSEcCtD
Rufinamide—GRM5—GPCR ligand binding—HTR2A—migraine	5.35e-05	0.00129	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—BDNF—migraine	5.32e-05	0.00128	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—HTR1B—migraine	5.31e-05	0.00127	CbGpPWpGaD
Rufinamide—Dizziness—Gabapentin—migraine	5.28e-05	0.00102	CcSEcCtD
Rufinamide—CYP3A4—central nervous system—migraine	5.21e-05	0.00202	CbGeAlD
Rufinamide—CYP2E1—brain—migraine	5.14e-05	0.002	CbGeAlD
Rufinamide—GRM5—GPCR downstream signaling—HTR1A—migraine	5.11e-05	0.00123	CbGpPWpGaD
Rufinamide—Nausea—Timolol—migraine	5.1e-05	0.000988	CcSEcCtD
Rufinamide—Vomiting—Gabapentin—migraine	5.08e-05	0.000984	CcSEcCtD
Rufinamide—Rash—Gabapentin—migraine	5.04e-05	0.000976	CcSEcCtD
Rufinamide—Dermatitis—Gabapentin—migraine	5.03e-05	0.000975	CcSEcCtD
Rufinamide—GRM5—GPCR downstream signaling—NPS—migraine	5.03e-05	0.00121	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—TAC1—migraine	5.03e-05	0.00121	CbGpPWpGaD
Rufinamide—Headache—Gabapentin—migraine	5.01e-05	0.00097	CcSEcCtD
Rufinamide—Hypersensitivity—Topiramate—migraine	4.95e-05	0.00096	CcSEcCtD
Rufinamide—GRM5—GPCR downstream signaling—HTR2C—migraine	4.93e-05	0.00118	CbGpPWpGaD
Rufinamide—Asthenia—Topiramate—migraine	4.82e-05	0.000935	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—HTR1B—migraine	4.82e-05	0.00116	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—EDNRA—migraine	4.8e-05	0.00115	CbGpPWpGaD
Rufinamide—Pruritus—Topiramate—migraine	4.76e-05	0.000922	CcSEcCtD
Rufinamide—Nausea—Gabapentin—migraine	4.75e-05	0.00092	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—HTR1D—migraine	4.7e-05	0.00113	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HTR1A—migraine	4.64e-05	0.00111	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—CALCA—migraine	4.62e-05	0.00111	CbGpPWpGaD
Rufinamide—Diarrhoea—Topiramate—migraine	4.6e-05	0.000891	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—TAC1—migraine	4.57e-05	0.0011	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—NPS—migraine	4.57e-05	0.0011	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—HTR2A—migraine	4.49e-05	0.00108	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HTR2C—migraine	4.48e-05	0.00108	CbGpPWpGaD
Rufinamide—Dizziness—Topiramate—migraine	4.45e-05	0.000861	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—HTR2B—migraine	4.37e-05	0.00105	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EDNRA—migraine	4.36e-05	0.00105	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—HTR7—migraine	4.32e-05	0.00104	CbGpPWpGaD
Rufinamide—Vomiting—Topiramate—migraine	4.27e-05	0.000828	CcSEcCtD
Rufinamide—Rash—Topiramate—migraine	4.24e-05	0.000821	CcSEcCtD
Rufinamide—Dermatitis—Topiramate—migraine	4.23e-05	0.000821	CcSEcCtD
Rufinamide—Headache—Topiramate—migraine	4.21e-05	0.000816	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—CALCA—migraine	4.19e-05	0.00101	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—MTHFR—migraine	4.14e-05	0.000994	CbGpPWpGaD
Rufinamide—Nausea—Topiramate—migraine	3.99e-05	0.000774	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—HTR7—migraine	3.92e-05	0.000942	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—LRP1—migraine	3.85e-05	0.000923	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—MTHFR—migraine	3.37e-05	0.000809	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TRPM8—migraine	3.15e-05	0.000757	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—HTR2A—migraine	3.03e-05	0.000727	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NOTCH4—migraine	2.95e-05	0.000708	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR1B—migraine	2.85e-05	0.000683	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HTR2A—migraine	2.75e-05	0.00066	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR1A—migraine	2.74e-05	0.000658	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TAC1—migraine	2.7e-05	0.000648	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NPS—migraine	2.7e-05	0.000648	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PGR—migraine	2.7e-05	0.000648	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—MTHFR—migraine	2.68e-05	0.000642	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR2C—migraine	2.65e-05	0.000635	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EDNRA—migraine	2.57e-05	0.000618	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NOTCH3—migraine	2.51e-05	0.000602	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CALCA—migraine	2.48e-05	0.000595	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	2.39e-05	0.000574	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	2.39e-05	0.000574	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR7—migraine	2.32e-05	0.000556	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—HTR3A—migraine	2.03e-05	0.000488	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TGFBR2—migraine	2e-05	0.000479	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—TNF—migraine	1.93e-05	0.000464	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TNF—migraine	1.87e-05	0.000449	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—TNF—migraine	1.78e-05	0.000428	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TNF—migraine	1.67e-05	0.0004	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HTR2A—migraine	1.62e-05	0.00039	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TNF—migraine	1.53e-05	0.000366	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TNF—migraine	1.45e-05	0.000348	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ESR1—migraine	1.44e-05	0.000346	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—migraine	1.23e-05	0.000296	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—migraine	1.18e-05	0.000283	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—migraine	1.15e-05	0.000277	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—migraine	1.13e-05	0.000272	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—migraine	1.13e-05	0.000272	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—migraine	1.09e-05	0.000262	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—migraine	1.09e-05	0.000262	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CACNA1A—migraine	9.41e-06	0.000226	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CACNA1A—migraine	8.09e-06	0.000194	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—migraine	7.68e-06	0.000184	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CACNA1A—migraine	4.37e-06	0.000105	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—migraine	3.11e-06	7.48e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—migraine	2.68e-06	6.43e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—migraine	1.44e-06	3.47e-05	CbGpPWpGaD
